Difference between revisions of "Li-Fraumeni syndrome"

Jump to navigation Jump to search
more
(create)
 
(more)
Line 1: Line 1:
'''Li-Fraumeni syndrome''' is due to germline mutations in the gene TP53 (p53),<ref>{{OMIM|191170}}</ref> an important regulator of apoptosis and the cell cycle, i.e. cell division.  It is implicated in a very large number of sporadic cancer.
'''Li-Fraumeni syndrome''' is due to germline mutations in the gene TP53 (p53),<ref>{{OMIM|191170}}</ref> an important regulator of apoptosis and the cell cycle, i.e. cell division.  It is implicated in a very large number of sporadic cancer.


Individuals with Li-Fraumeni syndrome are predisposed to cancer.
Individuals with Li-Fraumeni syndrome are predisposed to cancer.  TP53 is considered to be a tumour suppressor and like most tumour suppressors, inheritance is autosomal dominant.


==Associated cancers==
==Associated cancers==
This is not an exhaustive list:
This is not an exhaustive list:
*[[Adrenocortical carcinoma]].<ref name=Ref_PBoD8_1157>{{Ref PBoD8|1157}}</ref>
*[[Adrenocortical carcinoma]].<ref name=Ref_PBoD8_1157>{{Ref PBoD8|1157}}</ref>
*[[Breast cancer]].<ref name=emed987356ov>URL: [http://emedicine.medscape.com/article/987356-overview http://emedicine.medscape.com/article/987356-overview]. Accessed on: 19 March 2011.</ref>
*[[Osteosarcoma]].<ref name=emed987356ov/>
*[[Chondrosarcoma]].<ref name=emed987356ov/>
*[[Brain tumours]].<ref name=emed987356ov/>
*Acute [[leukemia]].<ref name=emed987356ov/>
*[[Soft tissue lesions|Soft tissue sarcomas]].<ref name=emed987356ov/>


==See also==
==See also==
48,830

edits

Navigation menu